483 Aurobindo Pharma (Unit III) Jun 2015

483 Aurobindo Pharma (Unit III) Jun 2015

Sangeeta Khurana FDA, Pratik Upadhyay FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma (Unit III) - Medchal, India facility and issued 2 inspectional observations (via FDA 483) on 26 Jun 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 26 Jun 2015
  • Location: Medchal, India
  • FEI: 3004021229
Add To Cart